180 Life Sciences Corp. Quarterly Net Income (Loss) Attributable to Parent in USD from Q4 2016 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
180 Life Sciences Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q4 2016 to Q3 2024.
  • 180 Life Sciences Corp. Net Income (Loss) Attributable to Parent for the quarter ending September 30, 2024 was -$837K, a 91.8% increase year-over-year.
  • 180 Life Sciences Corp. Net Income (Loss) Attributable to Parent for the twelve months ending September 30, 2024 was -$3.12M, a 92.3% increase year-over-year.
  • 180 Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$19.9M, a 48.5% increase from 2022.
  • 180 Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2022 was -$38.7M, a 90.5% decline from 2021.
  • 180 Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2021 was -$20.3M, a 86.7% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$3.12M -$837K +$9.43M +91.8% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q2 2024 -$12.6M $11.8K +$3.69M Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-14
Q1 2024 -$16.2M -$1.07M +$3.69M +77.5% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-14
Q4 2023 -$19.9M -$1.23M +$20.5M +94.4% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-25
Q3 2023 -$40.5M -$10.3M +$11.2M +52.2% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 -$51.7M -$3.68M -$6.62M -225% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-14
Q1 2023 -$45.1M -$4.76M -$6.33M -405% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-14
Q4 2022 -$38.7M -$21.7M -$22.8M -2198% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-25
Q3 2022 -$15.9M -$21.5M -$39.8M -217% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $23.8M $2.94M +$26.4M Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-09
Q1 2022 -$2.56M $1.56M +$17.8M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-09
Q4 2021 -$20.3M $1.04M +$8.98M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-31
Q3 2021 -$29.3M $18.3M +$19.1M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 -$48.4M -$23.5M -$23.7M -8874% Apr 1, 2021 Jun 30, 2021 10-Q 2022-11-10
Q1 2021 -$24.7M -$16.2M -$13.8M -580% Jan 1, 2021 Mar 31, 2021 10-Q 2022-11-10
Q4 2020 -$10.9M -$7.94M +$17.7M +69% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-31
Q3 2020 -$28.5M -$829K -$808K -3706% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-15
Q2 2020 -$27.7M $267K +$278K Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-16
Q1 2020 -$28M -$2.38M -$2.61M -1128% Jan 1, 2020 Mar 31, 2020 10-Q 2021-07-19
Q4 2019 -$25.4M -$25.6M -$25.9M -7710% Oct 1, 2019 Dec 31, 2019 10-K 2021-07-09
Q3 2019 $535K -$21.8K -$341K -107% Jul 1, 2019 Sep 30, 2019 10-Q/A 2021-02-05
Q2 2019 $877K -$10.8K -$222K -105% Apr 1, 2019 Jun 30, 2019 10-Q/A 2021-02-05
Q1 2019 $1.1M $232K +$58.1K +33.5% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-24
Q4 2018 $1.04M $336K +$273K +429% Oct 1, 2018 Dec 31, 2018 10-K 2020-04-07
Q3 2018 $768K $320K +$233K +271% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $534K $211K +$206K +3890% Apr 1, 2018 Jun 30, 2018 10-Q 2019-11-12
Q1 2018 $328K $173K +$205K Jan 1, 2018 Mar 31, 2018 10-Q 2019-11-12
Q4 2017 $124K $63.6K +$66.7K Oct 1, 2017 Dec 31, 2017 10-K 2019-04-01
Q3 2017 $57K $86.1K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-09
Q2 2017 $5.29K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 -$31.3K Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-15
Q4 2016 -$3.11K Sep 7, 2016 Dec 31, 2016 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.